To be announced
To be announced
To be announced
To be announced
To be announced
NSE/BSE
To be announced
We are engaged in the distribution and supply of a diversified portfolio of solvents, specialty chemicals, acids, monomers, pharmaceutical raw materials and nutraceuticals. With over two decades of operational experience in the chemical industry, we have developed sourcing relationships with domestic and international suppliers, enabling us to procure a broad range of chemical
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 50% | 95,75,700 crores |
| Non-Institutional Investors (NIIs) | 35% | 67,02,990 crores |
| Retail Individual Investors (RIIs) | 15% | 28,72,710 crores |
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| -- | -- | -- |
| Issue Composition: | |
|---|---|
| Face Value | ₹10 per share |
| Total Issue Size | 1,91,51,400 shares (aggregating up to To be announced) |
| Fresh Issue | 11,86,910 shares (aggregating up to ₹1,18,69,100 crores) |
| Offer for Sale | 7,28,230 shares of ₹10 (aggregating up to ₹72,82,300 crores) |
| Issue Type | Book Building IPO |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | 98.5 shares |
| Post-Issue Shareholding | 0 shares |
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Ujin Pharma ipo has been designed to ensure broad participation while maintaining optimal price discovery.
610/6th Floor Neelkanth Corporate Park Kirol Road Mumbai
Kfin Technologies Ltd.
| Book Running Lead Manager(s) |
|---|
| SMC Capitals Ltd | Marwadi Chandarana Intermediaries Brokers Pvt Ltd |